Search results for "CAR-T therapy"

FDA Clears Trial for Next-Gen CAR-T Therapy That Creates Cancer-Fighting Cells Inside Patients

FDA Clears Trial for Next-Gen CAR-T Therapy That Creates Cancer-Fighting Cells Inside Patients

CAR-T therapy for blood cancers conventionally involves removing a patient’s immune cells, modifying them in a laboratory to attack cancer cells, and...
GC Cell Administers Experimental CAR-NK Therapy at Seoul National University Hospital Following MFDS Approval

GC Cell Administers Experimental CAR-NK Therapy at Seoul National University Hospital Following MFDS Approval

GC Cell announced on Sept. 18 that South Korea’s Ministry of Food and Drug Safety has approved the compassionate use of its investigational cell...
Samsung Medical Center Ranks No. 5 Globally for Cancer Care in Newsweek 2027 Assessment, Climbing to No. 12 in Respiratory Medicine

Samsung Medical Center Ranks No. 5 Globally for Cancer Care in Newsweek 2027 Assessment, Climbing to No. 12 in Respiratory Medicine

Samsung Medical Center has been named the No. 5 hospital worldwide and No. 1 in South Korea for cancer treatment,...
Immuncell-LC Demonstrates Potential in Preventing Liver Cancer Recurrence Following Organ Transplant

Immuncell-LC Demonstrates Potential in Preventing Liver Cancer Recurrence Following Organ Transplant

A new study suggests that Immuncell-LC, an autologous immune cell therapy, may effectively curb cancer recurrence in...
Radiation Therapy Shrinks Lymph-Node Tumors in 75% of Advanced Liver Cancer Cases

Radiation Therapy Shrinks Lymph-Node Tumors in 75% of Advanced Liver Cancer Cases

When hepatocellular carcinoma spreads to the lymph nodes, it is classified as advanced liver cancer, typically...
Gachon University Gil Medical Center Expands Advanced Blood Cancer Care as Regional CAR-T Center Reaches Two-Year Milestone

Gachon University Gil Medical Center Expands Advanced Blood Cancer Care as Regional CAR-T Center Reaches Two-Year Milestone

For patients with aggressive blood cancers that recur or fail to respond to standard chemotherapy, chimeric antigen...
Yonsei Cancer Center Expands Carbon-Ion Therapy to Head and Neck Cancers, Sarcomas, and Recurrent Rectal Cancers

Yonsei Cancer Center Expands Carbon-Ion Therapy to Head and Neck Cancers, Sarcomas, and Recurrent Rectal Cancers

For patients facing cancers that are anatomically difficult to operate on or resistant to conventional radiation—as...
CAR-T Without Extracting Patient Cells? J&J Makes $785 Million Bet on In Vivo Therapy

CAR-T Without Extracting Patient Cells? J&J Makes $785 Million Bet on In Vivo Therapy

Johnson & Johnson (J&J) is investing more than $785 million (approximately 1.11 trillion won) in next-generation "in...
MediPost Begins Pivotal U.S. Phase 3 Trial for Regenerative Knee Therapy Cartistem

MediPost Begins Pivotal U.S. Phase 3 Trial for Regenerative Knee Therapy Cartistem

South Korean biotechnology company MediPost has entered full-scale Phase 3 clinical testing in the United States for...
Slowing the Inevitable: How Early Antibody Therapy Is Transforming Alzheimer’s Care

Slowing the Inevitable: How Early Antibody Therapy Is Transforming Alzheimer’s Care

“Lately, I keep forgetting appointments.” “They keep repeating what they just said.” When memory lapses in a parent...